ADMT Swings to Q3 Loss Amid Investment Hit, Revenue Up
Ticker: ADMT · Form: 10-Q · Filed: Nov 14, 2025 · CIK: 849401
| Field | Detail |
|---|---|
| Company | Adm Tronics Unlimited, Inc. (ADMT) |
| Form Type | 10-Q |
| Filed Date | Nov 14, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $250,000 |
| Sentiment | mixed |
Sentiment: mixed
Topics: Medical Devices, Contract Manufacturing, Specialty Chemicals, Quarterly Earnings, Investment Losses, Operating Cash Flow, Small Cap
TL;DR
**ADMT's Q3 loss is a red flag, despite revenue growth, indicating underlying profitability issues and investment volatility that traders should eye cautiously.**
AI Summary
ADM Tronics Unlimited, Inc. (ADMT) reported a net loss of $114,672 for the three months ended September 30, 2025, a significant increase from the $52,687 net loss in the prior-year period. However, for the six months ended September 30, 2025, the company posted a net income of $212,962, a slight decrease from $219,481 in the same period of 2024. Revenue increased to $887,498 for the three months ended September 30, 2025, up from $840,036 in 2024, and to $1,861,173 for the six-month period, compared to $1,697,881 in 2024. Gross profit declined to $375,797 for the three-month period from $418,782, and to $857,090 for the six-month period from $939,685. A notable change was a $111,000 loss from investment in the three months ended September 30, 2025, contrasting with a $1,000 loss in the prior year, and a $114,750 gain from investment for the six-month period. Total assets increased to $2,160,123 as of September 30, 2025, from $2,127,871 at March 31, 2025, while total liabilities decreased from $1,456,525 to $1,279,699.
Why It Matters
ADMT's mixed financial performance, with increased revenue but a Q3 net loss driven by investment losses, signals volatility for investors. While the company's strategic focus on medical devices and chemical products offers niche market potential, the decline in gross profit and fluctuating investment gains/losses suggest operational challenges and an unpredictable earnings stream. Competitors in the contract manufacturing and specialty chemicals sectors may capitalize on ADMT's inconsistent profitability. Employees and customers should monitor the company's ability to stabilize its financial results and execute on its business lines, especially given the competitive landscape in medical device manufacturing and chemical product sales.
Risk Assessment
Risk Level: medium — The company reported a net loss of $114,672 for the three months ended September 30, 2025, a significant deterioration from the prior year's $52,687 loss, primarily due to a $111,000 loss from investment. While total assets increased to $2,160,123 and liabilities decreased, the negative cash flow from operating activities of $63,282 for the six months ended September 30, 2025, indicates ongoing operational cash burn.
Analyst Insight
Investors should exercise caution and conduct further due diligence on ADMT's investment strategy and operational efficiency. Monitor future filings for sustained profitability and positive cash flow from operations, as the current Q3 loss and operating cash burn suggest potential instability despite revenue growth.
Financial Highlights
- debt To Equity
- 1.45
- revenue
- $887,498
- operating Margin
- 0.29%
- total Assets
- $2,160,123
- total Debt
- $1,279,699
- net Income
- -$114,672
- eps
- N/A
- gross Margin
- 42.34%
- cash Position
- $321,224
- revenue Growth
- +5.65%
Key Numbers
- $114,672 — Net loss for Q3 2025 (Increased from $52,687 net loss in Q3 2024)
- $212,962 — Net income for six months ended Sept 30, 2025 (Slight decrease from $219,481 in 2024)
- $887,498 — Net revenues for Q3 2025 (Increased from $840,036 in Q3 2024)
- $1,861,173 — Net revenues for six months ended Sept 30, 2025 (Increased from $1,697,881 in 2024)
- $111,000 — Loss from investment for Q3 2025 (Significant increase from $1,000 loss in Q3 2024)
- $1,279,699 — Total liabilities as of Sept 30, 2025 (Decreased from $1,456,525 at March 31, 2025)
- $63,282 — Net cash used in operating activities for six months ended Sept 30, 2025 (Indicates operational cash burn)
- 67,588,492 — Shares outstanding (As of November 14, 2025)
- $321,224 — Cash and cash equivalents as of Sept 30, 2025 (Decreased from $382,969 at March 31, 2025)
- $880,424 — Total stockholders' equity as of Sept 30, 2025 (Increased from $671,346 at March 31, 2025)
Key Players & Entities
- ADM Tronics Unlimited, Inc. (company) — Registrant
- Sonotron Medical Systems, Inc. (company) — Wholly owned subsidiary
- SEC (regulator) — Securities and Exchange Commission
- FDA (regulator) — Food and Drug Administration
- FASB (regulator) — Financial Accounting Standards Board
- FDIC (regulator) — Federal Deposit Insurance Corporation
- Delaware (company) — State of incorporation
- United States (company) — Primary market for products
- Australia (company) — Market for chemical products
- Europe (company) — Market for chemical products
FAQ
What were ADM Tronics Unlimited's net revenues for the three months ended September 30, 2025?
ADM Tronics Unlimited reported net revenues of $887,498 for the three months ended September 30, 2025, an increase from $840,036 in the same period of 2024.
Did ADM Tronics Unlimited achieve a net profit or loss in the third quarter of 2025?
ADM Tronics Unlimited reported a net loss of $114,672 for the three months ended September 30, 2025, compared to a net loss of $52,687 in the prior-year period.
What was the primary reason for the increased net loss for ADM Tronics Unlimited in Q3 2025?
The primary reason for the increased net loss was a significant loss from investment of $111,000 for the three months ended September 30, 2025, compared to a $1,000 loss in the same period of 2024.
How did ADM Tronics Unlimited's cash and cash equivalents change as of September 30, 2025?
Cash and cash equivalents for ADM Tronics Unlimited decreased to $321,224 as of September 30, 2025, from $382,969 at March 31, 2025.
What are the main business lines of ADM Tronics Unlimited, Inc.?
ADM Tronics Unlimited's principal lines of business include the design, manufacture, and sale of electronics (including medical devices and spa controllers), the production and sale of chemical and antistatic products, and research, development, and engineering services.
What was ADM Tronics Unlimited's gross profit for the six months ended September 30, 2025?
ADM Tronics Unlimited's gross profit for the six months ended September 30, 2025, was $857,090, a decrease from $939,685 in the same period of 2024.
How many shares of common stock did ADM Tronics Unlimited have outstanding as of November 14, 2025?
ADM Tronics Unlimited had 67,588,492 shares of common stock outstanding as of November 14, 2025.
What was the change in ADM Tronics Unlimited's total liabilities from March 31, 2025, to September 30, 2025?
ADM Tronics Unlimited's total liabilities decreased from $1,456,525 at March 31, 2025, to $1,279,699 as of September 30, 2025.
Does ADM Tronics Unlimited have any significant legal proceedings?
The filing indicates that Item 1, 'Legal Proceedings,' is included in Part II - Other Information, but no specific details are provided in the excerpt to answer this question.
What is ADM Tronics Unlimited's approach to long-term inventory?
Due to recent material shortages, ADM Tronics Unlimited purchases items it believes will be used in the future, even beyond the current fiscal year, as they become available, classifying them as long-term inventory.
Risk Factors
- Investment Losses Impacting Profitability [medium — financial]: The company experienced a significant loss from investments of $111,000 in the three months ended September 30, 2025, a substantial increase from the $1,000 loss in the prior year period. This volatility in investment performance can negatively impact overall net income and financial stability.
- Declining Gross Profit Margins [medium — operational]: Gross profit decreased to $375,797 for the three months ended September 30, 2025, down from $418,782 in the same period of 2024. For the six-month period, gross profit declined to $857,090 from $939,685. This indicates rising costs of sales relative to revenue, potentially squeezing profitability.
- Increased Net Loss in Third Quarter [medium — operational]: ADM Tronics reported a net loss of $114,672 for the three months ended September 30, 2025, a significant deterioration from a net loss of $52,687 in the prior-year period. This widening loss highlights challenges in managing expenses or generating sufficient revenue to cover costs.
- Operational Cash Burn [high — financial]: The company used $63,282 in net cash for operating activities during the six months ended September 30, 2025. This negative operating cash flow indicates that the core business operations are consuming cash rather than generating it, which could strain liquidity if not addressed.
- Decreasing Cash Reserves [medium — financial]: Cash and cash equivalents decreased to $321,224 as of September 30, 2025, from $382,969 at March 31, 2025. This reduction in liquidity, coupled with negative operating cash flow, warrants close monitoring.
- High Leverage Relative to Equity [medium — financial]: While total liabilities decreased to $1,279,699 from $1,456,525, the company's total stockholders' equity increased to $880,424 from $671,346. However, the substantial liabilities still represent a significant portion of the capital structure.
Industry Context
ADM Tronics operates in a sector that often involves specialized manufacturing and potentially niche markets. The industry can be sensitive to technological advancements, regulatory changes, and the demand for specific products. Competition can arise from both larger, established players and smaller, agile companies.
Regulatory Implications
The company must adhere to various financial reporting regulations, including those set by the SEC. Any misstatements or non-compliance can lead to penalties and reputational damage. Specific industry regulations related to its products or services would also need to be managed.
What Investors Should Do
- Monitor operating expenses closely.
- Analyze the volatility of investment income/loss.
- Evaluate the sustainability of current cash levels.
- Assess the trend in gross profit margins.
Key Dates
- 2025-09-30: End of Third Quarter and Six-Month Period — Reporting period for the financial results discussed in the 10-Q, showing revenue growth but increased net loss for the quarter and a slight decrease in net income for the six months.
- 2025-03-31: End of Fiscal Year — Balance sheet comparison point, showing changes in assets, liabilities, and equity from the prior fiscal year-end to the current reporting period.
Glossary
- Accumulated deficit
- The total net losses of a company since its inception that have not been offset by net income. (Indicates the company has historically incurred more expenses than revenues, impacting its retained earnings.)
- Operating lease right-of-use asset
- An asset recognized under accounting standards for the right to use an asset for the lease term. (Represents the company's long-term commitments for leased assets, impacting its balance sheet and expenses.)
- Loan receivable, net of allowance for doubtful accounts
- The amount of money lent to others that the company expects to collect, after accounting for potential uncollectible amounts. (Shows the company's exposure to credit risk on its lending activities.)
- Intangible assets, net of accumulated amortization
- Non-physical assets (like patents or goodwill) that have a finite useful life, with their cost spread over that life. (Represents value derived from non-physical assets, which are being expensed over time.)
- Gross Profit
- The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. (A key indicator of the company's pricing strategy and cost management in its core operations.)
Year-Over-Year Comparison
Compared to the prior year, ADM Tronics Unlimited, Inc. saw revenue growth for both the three-month period ended September 30, 2025 ($887,498 vs $840,036) and the six-month period ($1,861,173 vs $1,697,881). However, gross profit declined in both periods, indicating rising costs. The company also experienced a significant increase in net loss for the third quarter ($114,672 vs $52,687), although net income for the six-month period remained relatively stable ($212,962 vs $219,481). A notable new risk factor emerged with a substantial investment loss of $111,000 in the third quarter, compared to a minimal loss previously.
Filing Stats: 4,399 words · 18 min read · ~15 pages · Grade level 14.9 · Accepted 2025-11-14 16:01:11
Key Financial Figures
- $250,000 — Corporation ("FDIC") up to a maximum of $250,000. At September 30, 2025 and March 31, 20
Filing Documents
- admt20250930_10q.htm (10-Q) — 1037KB
- ex_887890.htm (EX-21.1) — 1KB
- ex_885369.htm (EX-31.1) — 9KB
- ex_885370.htm (EX-32.1) — 5KB
- 0001437749-25-035161.txt ( ) — 5376KB
- admt-20250930.xsd (EX-101.SCH) — 48KB
- admt-20250930_def.xml (EX-101.DEF) — 329KB
- admt-20250930_lab.xml (EX-101.LAB) — 293KB
- admt-20250930_pre.xml (EX-101.PRE) — 362KB
- admt-20250930_cal.xml (EX-101.CAL) — 48KB
- admt20250930_10q_htm.xml (XML) — 803KB
- Financial Information
Part I - Financial Information Item 1. Condensed Consolidated Financial Statements (unaudited): Condensed Consolidated Balance Sheets –September 30, 2025 (unaudited) and March 31, 2025 3 Condensed Consolidated Statements of Operations for the six ended September 30, 2025 and 2024 (unaudited) 4 Condensed Consolidated Statement of Stockholders' Equity for the six months ended September 30, 2025 and 2024 (unaudited) 5 Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2025 and 2024 (unaudited) 6 Notes to Condensed Consolidated Financial Statements 7 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 22 Item 4.
Controls and Procedures
Controls and Procedures 23
- Other Information
Part II - Other Information Item 1.
Legal Proceedings
Legal Proceedings 23 Item 1A.
Risk Factors
Risk Factors 23 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22 Item 3. Defaults Upon Senior Securities 22 Item 4. Mine Safety Disclosures 22 Item 5. Other Information 22 Item 6. Exhibits 24
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) September 30, March 31, 2025 2025 ASSETS Current assets: Cash and cash equivalents $ 321,224 $ 382,969 Accounts receivable, net of credit losses of $ 975,597 at September 30, 2025 and March 31, 2025, respectively 551,708 528,383 Inventories 368,157 336,270 Prepaid expenses and other current assets 6,268 1,800 Total current assets 1,247,357 1,249,422 Other Assets: Long-term inventory 203,206 220,401 Operating lease right-of-use asset 268,333 313,189 Loan receivable, net of allowance for doubtful accounts of $ 240,965 at September 30, 2025 and March 31, 2025, respectively. 89,125 89,125 Investments 340,500 225,750 Intangible assets, net of accumulated amortization of $ 38,707 and $ 35,242 at September 30, 2025 and March 31, 2025, respectively 11,602 15,067 Other assets - 14,917 Total other assets 912,766 878,449 Total assets $ 2,160,123 $ 2,127,871 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 307,899 $ 299,007 Bank overdraft 86,338 147,503 Accrued expenses and other current liabilities 19,879 29,240 PPP loan - 896 Line of credit 379,594 377,161 Operating lease liability 93,373 93,373 Customer deposits 131,343 201,968 Total current liabilities 1,018,426 1,149,148 Long-term liabilities Due to employee 79,449 79,449 Operating lease liability less current portion 181,824 227,928 Total long-term liabilities 261,273 307,377 Total liabilities 1,279,699 1,456,525 Stockholders' equity: Preferred stock, $ .01 par value; 5,000,000 shares authorized, no shares issued and outstanding - - Common stock, $ 0.0005 par value; 150,000,000 shares authorized, 67,588,492 shares issued and outstanding 33,794 33,794 Additional paid-in capital 33,607,772 33,